NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing lossSimeng Lu(Harvard University), Lei Xu(Massachusetts General Hospital)Nature CommunicationsFebruary 11, 202610.1038/s41467-026-68865-8Cited by 0SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis